BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 33390169)

  • 1. Cytokine-chemokine network driven metastasis in esophageal cancer; promising avenue for targeted therapy.
    Bhat AA; Nisar S; Maacha S; Carneiro-Lobo TC; Akhtar S; Siveen KS; Wani NA; Rizwan A; Bagga P; Singh M; Reddy R; Uddin S; Grivel JC; Chand G; Frenneaux MP; Siddiqi MA; Bedognetti D; El-Rifai W; Macha MA; Haris M
    Mol Cancer; 2021 Jan; 20(1):2. PubMed ID: 33390169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokines driven ovarian cancer progression, metastasis and chemoresistance: Potential pharmacological targets for cancer therapy.
    Bose S; Saha P; Chatterjee B; Srivastava AK
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):568-579. PubMed ID: 35378273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine- and chemokine-induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy.
    Bhat AA; Nisar S; Singh M; Ashraf B; Masoodi T; Prasad CP; Sharma A; Maacha S; Karedath T; Hashem S; Yasin SB; Bagga P; Reddy R; Frennaux MP; Uddin S; Dhawan P; Haris M; Macha MA
    Cancer Commun (Lond); 2022 Aug; 42(8):689-715. PubMed ID: 35791509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Roles of Stroma-Derived Chemokine in Different Stages of Cancer Metastases.
    Hussain S; Peng B; Cherian M; Song JW; Ahirwar DK; Ganju RK
    Front Immunol; 2020; 11():598532. PubMed ID: 33414786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokines and Their Receptors: Predictors of Therapeutic Potential in Tumor Microenvironment on Esophageal Cancer.
    Huang CG; Liu Q; Zheng ST; Liu T; Tan YY; Peng TY; Chen J; Lu XM
    Dig Dis Sci; 2024 May; 69(5):1562-1570. PubMed ID: 38580886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of pancreatic cancer therapy resistance by chemokines.
    Gautam SK; Basu S; Aithal A; Dwivedi NV; Gulati M; Jain M
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):69-80. PubMed ID: 36064086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advance in the role of chemokines/chemokine receptors in carcinogenesis: Focus on pancreatic cancer.
    Song N; Cui K; Zeng L; Li M; Fan Y; Shi P; Wang Z; Su W; Wang H
    Eur J Pharmacol; 2024 Mar; 967():176357. PubMed ID: 38309677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.
    Erin N; Grahovac J; Brozovic A; Efferth T
    Drug Resist Updat; 2020 Dec; 53():100715. PubMed ID: 32679188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conditioning solid tumor microenvironment through inflammatory chemokines and S100 family proteins.
    Nasser MW; Elbaz M; Ahirwar DK; Ganju RK
    Cancer Lett; 2015 Aug; 365(1):11-22. PubMed ID: 25963887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokines and their receptors in esophageal cancer--the systematic review and future perspectives.
    Łukaszewicz-Zając M; Mroczko B; Szmitkowski M
    Tumour Biol; 2015 Aug; 36(8):5707-14. PubMed ID: 26130416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokines and cytokines: Axis and allies in prostate cancer pathogenesis.
    Mughees M; Kaushal JB; Sharma G; Wajid S; Batra SK; Siddiqui JA
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):497-512. PubMed ID: 35181473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory Components of the Thyroid Cancer Microenvironment: An Avenue for Identification of Novel Biomarkers.
    Jarboe T; Tuli NY; Chakraborty S; Maniyar RR; DeSouza N; Xiu-Min Li ; Moscatello A; Geliebter J; Tiwari RK
    Adv Exp Med Biol; 2021; 1350():1-31. PubMed ID: 34888842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine Interaction With Cancer-Associated Fibroblasts in Esophageal Cancer.
    Hassan MS; Cwidak N; Awasthi N; von Holzen U
    Cancer Control; 2022; 29():10732748221078470. PubMed ID: 35442094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy.
    Morein D; Erlichman N; Ben-Baruch A
    Front Immunol; 2020; 11():952. PubMed ID: 32582148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor microenvironment and noncoding RNAs as co-drivers of epithelial-mesenchymal transition and cancer metastasis.
    Drak Alsibai K; Meseure D
    Dev Dyn; 2018 Mar; 247(3):405-431. PubMed ID: 28691356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokine-Cytokine Networks in the Head and Neck Tumor Microenvironment.
    Nisar S; Yousuf P; Masoodi T; Wani NA; Hashem S; Singh M; Sageena G; Mishra D; Kumar R; Haris M; Bhat AA; Macha MA
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokines orchestrate tumor cells and the microenvironment to achieve metastatic heterogeneity.
    Saxena S; Singh RK
    Cancer Metastasis Rev; 2021 Jun; 40(2):447-476. PubMed ID: 33959849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Notch-1-mediated esophageal carcinoma EC-9706 cell invasion and metastasis by inducing epithelial-mesenchymal transition through Snail.
    Wang T; Xuan X; Pian L; Gao P; Hu H; Zheng Y; Zang W; Zhao G
    Tumour Biol; 2014 Feb; 35(2):1193-201. PubMed ID: 24022665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tumor microenvironment in esophageal cancer.
    Lin EW; Karakasheva TA; Hicks PD; Bass AJ; Rustgi AK
    Oncogene; 2016 Oct; 35(41):5337-5349. PubMed ID: 26923327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor microenvironment signaling and therapeutics in cancer progression.
    Goenka A; Khan F; Verma B; Sinha P; Dmello CC; Jogalekar MP; Gangadaran P; Ahn BC
    Cancer Commun (Lond); 2023 May; 43(5):525-561. PubMed ID: 37005490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.